PEDATA, FELICITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.712
EU - Europa 10.531
AS - Asia 6.764
SA - Sud America 916
Continente sconosciuto - Info sul continente non disponibili 306
AF - Africa 221
OC - Oceania 147
Totale 35.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.473
RU - Federazione Russa 3.440
SG - Singapore 2.090
IT - Italia 1.997
PL - Polonia 1.362
CN - Cina 1.361
HK - Hong Kong 1.079
IE - Irlanda 845
BR - Brasile 768
SE - Svezia 725
VN - Vietnam 682
KR - Corea 575
DE - Germania 569
FI - Finlandia 369
UA - Ucraina 350
FR - Francia 319
GB - Regno Unito 295
IN - India 201
TR - Turchia 173
CA - Canada 166
JP - Giappone 152
AU - Australia 145
JO - Giordania 79
BD - Bangladesh 73
CI - Costa d'Avorio 67
AR - Argentina 52
ID - Indonesia 49
CH - Svizzera 48
IQ - Iraq 43
NG - Nigeria 40
NL - Olanda 39
ES - Italia 33
AT - Austria 32
BE - Belgio 31
MX - Messico 30
IR - Iran 27
ZA - Sudafrica 25
PK - Pakistan 24
EC - Ecuador 23
VE - Venezuela 20
CO - Colombia 19
EG - Egitto 17
KE - Kenya 17
TW - Taiwan 16
MA - Marocco 15
SA - Arabia Saudita 15
PY - Paraguay 14
AE - Emirati Arabi Uniti 13
CR - Costa Rica 13
IL - Israele 13
PT - Portogallo 13
PH - Filippine 12
RO - Romania 12
HU - Ungheria 11
LT - Lituania 11
CZ - Repubblica Ceca 10
UZ - Uzbekistan 10
CL - Cile 9
AZ - Azerbaigian 8
TN - Tunisia 8
KZ - Kazakistan 7
MY - Malesia 7
PE - Perù 7
SC - Seychelles 7
AL - Albania 6
JM - Giamaica 6
TH - Thailandia 6
BH - Bahrain 5
BJ - Benin 5
KG - Kirghizistan 5
NP - Nepal 5
OM - Oman 5
AM - Armenia 4
AO - Angola 4
DK - Danimarca 4
DZ - Algeria 4
GT - Guatemala 4
LB - Libano 4
SN - Senegal 4
TT - Trinidad e Tobago 4
CY - Cipro 3
EU - Europa 3
GE - Georgia 3
MD - Moldavia 3
NI - Nicaragua 3
SV - El Salvador 3
BS - Bahamas 2
CG - Congo 2
ET - Etiopia 2
HN - Honduras 2
KH - Cambogia 2
MM - Myanmar 2
MU - Mauritius 2
MV - Maldive 2
NZ - Nuova Zelanda 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
Totale 35.275
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.025
Ashburn 1.703
Singapore 1.513
Fairfield 1.396
Warsaw 1.358
Chandler 936
Hong Kong 845
Dublin 840
Woodbridge 652
Cambridge 567
Seattle 560
Seoul 550
Houston 526
Wilmington 521
Jacksonville 494
San Jose 483
Milan 408
Beijing 375
Ann Arbor 280
Princeton 259
Buffalo 245
Dallas 233
Los Angeles 217
Lauterbourg 212
Ho Chi Minh City 211
Boston 209
The Dalles 208
Florence 192
Lawrence 186
Altamura 180
Rome 179
Boardman 171
Hanoi 170
Council Bluffs 157
Hefei 151
Tokyo 137
Melbourne 135
Moscow 133
Izmir 124
Mumbai 107
Helsinki 98
New York 98
San Diego 97
Medford 81
Munich 80
Shanghai 74
Bremen 73
Abidjan 67
Frankfurt am Main 67
Kent 63
Philadelphia 57
Falls Church 54
Naples 51
São Paulo 49
Norwalk 48
Toronto 48
Turku 46
Bern 40
Orem 40
Dearborn 38
Clifton 36
Paris 36
Abuja 35
Bologna 35
Redondo Beach 34
Brooklyn 33
London 32
Brussels 30
Chennai 30
Jakarta 30
Turin 30
Vienna 30
Montreal 29
Chicago 28
Dong Ket 28
Phoenix 28
Haiphong 26
Hillsboro 26
Palermo 26
Figino 24
Tianjin 24
Da Nang 22
Salt Lake City 22
Yubileyny 22
Genoa 21
Guangzhou 21
Verona 21
Baghdad 20
Rio de Janeiro 20
Belo Horizonte 19
Brasília 19
Bari 18
Stockholm 18
Venice 18
Andover 17
Atlanta 17
Barcelona 17
Denver 16
Frankfurt Am Main 16
Bury St Edmunds 15
Totale 23.106
Salva come PNG Salva come JPEG
Nome #
Activation of adenosine A 2B receptors and sphingosine kinase/sphingosine 1-phosphate signaling axis modulates the amplitude of outward K + currents and maturation of oligodendrocyte precursor cells 478
The selective block of adenosine A2Breceptors prevents neuronal death in CA1 hippocampus after oxygen glucose deprivation 415
Adenosine A2A Receptors Modulate Acute Injury and Neuroinflammation in Brain Ischemia. 368
Adenosine A2B receptors stimulation inhibits oligodendrocyte maturation by interacting with sphingosine kinase/sphingosine 1-phosphate signalling axis in primary purified oligodendrocyte cultures 355
Confocal microscopy and electrophysiological study of single patient corneal endothelium cell cultures 344
The selective block of adenosine A2B receptors protects synaptic transmission from damage induced by oxygen and glucose deprivation in the CA1 rat hippocampus 326
The Selective Antagonism of P2X7 and P2Y1 Receptors Prevents Synaptic Failure and Affects Cell Proliferation Induced by Oxygen and Glucose Deprivation in Rat Dentate Gyrus. 324
Acute visceral pain relief mediated by A(3)AR agonists in rats: involvement of N-type voltage-gated calcium channels 315
Selective adenosine A3 receptor stimulation inhibits voltage-dependent Ca2+ currents and Ca2+-activated K+ conductances in rat dorsal root ganglion neurons 310
The neuron-astrocyte-microglia triad in CA3 after chronic cerebral hypoperfusion in the rat: Protective effect of dipyridamole 299
The selective antagonism of adenosine A2Breceptors reduces the synaptic failure and neuronal death induced by oxygen and glucose deprivation in rat CA1 hippocampus in vitro 295
Time-course of protection by the selective A2A receptor antagonist SCH58261 after transient focal cerebral ischemia. 279
A Selective Histamine H4 Receptor Antagonist, JNJ7777120, Is Protective in a Rat Model of Transient Cerebral Ischemia 272
Adenosine and oxygen/glucose deprivation in the brain 253
A2b adenosine receptors: When outsiders may become an attractive target to treat brain ischemia or demyelination 253
Role of adenosine in oligodendrocyte precursor maturation 252
The neuron-astrocyte-microglia triad in a rat model of chronic cerebral hypoperfusion: Protective effect of dipyridamole 247
The selective antagonism of P2X(7) and P2Y(1) receptors prevents synaptic failure and affects cell proliferation induced by oxygen and glucose deprivation in rat dentate gyrus 243
From the 7th Joint Italian-German Purine Club Meeting to European Purine Club Meetings. 241
A2B Adenosine Receptors and Sphingosine 1-Phosphate Signaling Cross-Talk in Oligodendrogliogenesis 230
Adenosine in the Central Nervous System: Effects on Neurotransmission and Neuroprotection. 228
Adenosine and Oxygen/Glucose Deprivation in the Brain 224
Adenosine A2B receptors inhibit K+ currents and cell differentiation in cultured oligodendrocyte precursor cells and modulate sphingosine-1-phosphate signaling pathway 223
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: Molecular modeling and pharmacological studies. 223
Adenosine A3 receptor activation inhibits pro-nociceptive N-type Ca2+ currents and cell excitability in dorsal root ganglion neurons 219
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 216
A1 AND A2 ADENOSINE RECEPTORS MODULATE ACETYLCHOLINE RELEASE FROM BRAIN SLICES. 215
Equilibrative Nucleoside Transporter ENT1 as a Biomarker of Huntington Disease 214
Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow. 210
ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. 209
ARE THE NEUROCHEMICAL AND BEHAVIORAL CHANGES INDUCED BY LESIONS OF THE NUCLEUS BASALIS IN THE RAT A MODEL OF ALZHEIMER'S DISEASE? 208
Adenosine A2A antagonists are protective in in vivo and in vitro models of brain ischemia. 204
Inducible nitric oxide synthase appears and is co-expressed with the neuronal isoform in interneurons of the rat hippocampus after transient ischemia induced by middle cerebral artery occlusion. 203
Adenosine is present in rat brain synaptic vesicles. 203
UDP-glucose enhances outward K+currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors 201
ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia 200
Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N 196
Functional characterization of a novel adenosine A2B receptor agonist on short-term plasticity and synaptic inhibition during oxygen and glucose deprivation in the rat CA1 hippocampus 196
Acetylcholine modulates K+ and Na+ currents in human basal forebrain cholinergic neuroblasts through an autocrine/paracrine mechanism 194
Relationships between neurons expressing neuronal nitric oxide synthase, degree of microglia activation and animal survival. A study in the rat cortex after transient ischemia 189
Adenosine A2A receptor antagonism increases nNOS-immunoreactive neurons in the striatum of Huntington transgenic mice 189
Protective effects of carbonic anhydrase inhibition in brain ischaemia in vitro and in vivo models 189
Protective Effect of Adenosine A2B Receptor Agonist, BAY60-6583, Against Transient Focal Brain Ischemia in Rat 189
Adenosine extracellular levels in human brain gliomas: an intraoperative microdialysis study. 188
Antagonism of purinergic P2 receptors enhances neuronal survival and decreases ERK1/2 activation after oxygen-glucose deprivation in rat CA1 hippocampal slices 188
Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation. 187
Blue light effects in human keloid fibroblasts 186
CHANGES IN HIGH AFFINITY CHOLINE UPTAKE IN RAT CORTEX FOLLOWING LESIONS OF THE MAGNOCELLULAR FOREBRAIN NUCLEI. 186
Acetylcholine output from the cerebral cortex, choline uptake and muscarinic receptors in morphine dependent freely-moving rats. 184
Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats 183
Adenosine extracellular brain concentrations and role of A2A receptors in ischemia 180
Ecto-ATPase inhibition: ATP and adenosine release under physiological and ischemic in vivo conditions in the rat striatum. 180
Purinergic signalling in brain ischemia 179
CHANGES IN REGIONAL BRAIN ACETYLCHOLINE LEVELS DURING DRUG-INDUCED CONVULSIONS. 179
Blocking adenosine A2A receptors during oxigen-glucose deprivation delays anoxic depolarization and ameliorates neuronal survival in the rat CA1 hippocampus 176
Adenosine A2A antagonists are protective in in vivo and in vitro models of brain ischemia. 176
Adenosine A2A receptor antagonism increases neuronal nitric oxide syntase expression in the striatum of huntington transgenic mice 176
ACETYLCHOLINE RELEASE FROM RAT CORTICAL SLICES DURING POSTNATAL DEVELOPMENT AND AGING 175
Purinergic modulation of cortical Acetylcholine release is decreased in aging rats 175
Adenosine and Stroke 174
Extracellular levels of amino acids and choline in human high grade gliomas: An intraoperative microdialysis study 174
Chronic caffeine treatment reduces caffeine but not adenosine effects on cortical acetylcholine release. 174
Role of carbonic anhydrase in cerebral ischemia and carbonic anhydrase inhibitors as putative protective agents 174
Adenosine A2A receptor-selective stimulation reduces signaling pathways involved in the development of intestine ischemia and reperfusion injury 173
Low doses of the selective adenosine A2A receptor agonist CGS21680 are protective in a rat model of transient cerebral ischemia 172
Role of ATP P2Y1 receptor in the rat dentate gyrus after a severe ischemic insult 171
The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat 170
A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro. 167
P2 receptor antagonists prevent synaptic failure and extracellular signal-regulated kinase 1/2 activation induced by oxygen and glucose deprivation in rat CA1 hippocampus in vitro. 167
Selective adenosine A2A receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischemia 165
Adenosine A2A receptors inhibit delayed rectifier potassium currents and cell differentiation in primary purified oligodendrocyte culture 165
Pharmacological Characterization of P626, a Novel Dual Adenosine A2A/A2B Receptor Antagonist, on Synaptic Plasticity and during an Ischemic-like Insult in CA1 Rat Hippocampus 164
Expression of neuronal and inducible nitric oxide synthase in neuronal and glial cells after transient occlusion of the middle cerebral artery 164
Time-course of the protective effect of selective adenosine A2A receptor agonists and antagonists after brain focal ischemia in the rat 163
Phosphatidylserine increases Acetylcholine release from cortical slices in aged rats 162
Role of P1 and P2 purinergic receptors in the dentate gyrus during in vitro ischemia 162
The selective A(2A) receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. 160
P2X(7) receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat 160
Effects of intravenous administration of dipyridamole in a rat model of chronic cerebral ischemia 160
A2 ADENOSINE RECEPTORS: THEIR PRESENCE AND NEUROMODULATORY ROLE IN THE CENTRAL NERVOUS SYSTEM. 158
The protective effect of adenosine A2A receptor antagonism in cerebral ischemia 157
Human keloid cultured fibroblasts irradiated with blue LED light: evidence from an in vitro study 157
Uncovering the mechanisms of adenosine receptor-mediated pain control: Focus on the a3 receptor subtype 157
Effect of chronic administration of selective adenosine A2A receptor agonists and antagonists on cerebral injury evaluated up to seven days after focal ischemia in the rat 156
Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a New Scaffold To Develop Potent and Selective Human A3 Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand-Receptor Modeling Studies. 156
GM1 ganglioside facilitates the recovery of high-affinity choline uptake in the cerebral cortex of rats with a lesion of the nucleus basalis magnocellularis 155
Role of adenosine A2A receptors in cerebral ischemia 155
ADENOSINE AND MEMORY STORAGE: EFFECT OF A(1) AND A(2) RECEPTOR ANTAGONISTS. 155
MRS3997, a dual adenosine A2A/A2B receptor agonist, reduces brain ischemic damage and alleviates neuroinflammation in rats 154
A2B Adenosine Receptor as a New and Attractive Target to Treat Brain Ischemia or Demyelination 154
The selective antagonism of A2A adenosine receptors prevents synaptic failure induced by oxygen and glucose deprivation in rat dentate gyrus 154
CHOLINERGIC AND NORADRENERGIC DENERVATIONS DECREASE LABELLED PURINE RELEASE FROM ELECTRICALLY STIMULATED RAT CORTICAL SLICES. 154
CHANGES IN SYNAPTOSOMAL HIGH AFFINITY CHOLINE UPTAKE FOLLOWING ELECTRICAL STIMULATION OF GUINEA-PIG CORTICAL SLICES: EFFECT OF ATROPINE AND PHYSOSTIGMINE. 153
The selective A(2A) adenosine receptors stimulation reduces delayed rectifier potassium currents (I-K) and differentiation of cultured oligodendrocytes 153
The selective antagonism of P2Y1 purinergic receptors prevents synaptic failure and affects cell proliferation induced by in vitro ischemia in rat dentate gyrus 153
BIPHASIC EFFECT OF METHYLXANTHINES ON ACETYLCHOLINE RELEASE FROM ELECTRICALLY-STIMULATED BRAIN SLICES. 151
A2A receptors in neuroprotection of dopaminergic neurons. 151
Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists. 151
In vivo amino acid release from the striatum of aging rats: adenosine modulation 151
Cognitive impairment with vascular impairment and degeneration. 150
Totale 20.315
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.600
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.554 0 160 72 92 60 76 58 101 85 72 282 496
2022/20233.849 421 553 132 322 368 754 484 190 416 27 103 79
2023/20241.289 77 177 265 60 90 128 63 263 16 40 61 49
2024/20259.404 323 994 679 1.419 2.647 1.149 256 598 495 268 318 258
2025/202610.571 999 1.410 835 541 1.301 441 1.296 554 778 644 291 1.481
2026/2027346 310 36 0 0 0 0 0 0 0 0 0 0
Totale 35.597